EGFR and cancer: Beyond the extensively studied RTKs such as epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGFR), Axl has emerged as a promising target due to its role in cancer cell proliferation, migration, and invasion [14].